The company expired its plan on July 18, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
13,490 KRW | +7.06% | +3.13% | -8.11% |
02-14 | HansBiomed Corporation Reports Earnings Results for the First Quarter Ended December 31, 2023 | CI |
2023 | HansBiomed Corporation(KOSDAQ:A042520) added to S&P Global BMI Index | CI |
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-8.11% | 129M | |
+10.86% | 126B | |
-5.52% | 11.27B | |
+4.17% | 9.12B | |
+40.13% | 5.61B | |
-21.47% | 4.75B | |
+8.77% | 3.45B | |
-6.03% | 2.89B | |
-12.05% | 2.07B | |
-7.83% | 2.05B |
- Stock Market
- Equities
- A042520 Stock
- News HansBiomed Corporation
- HansBiomed Corporation's Equity Buyback announced on January 17, 2022, has expired with 246,000 shares, representing 2.46% for KRW 2,962.2 million.